GMO Benchmark-Free Allocation Fund Class IV
GBMBX
NASDAQ
| Weiss Ratings | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Company Info | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | GMO | |||
| Manager/Tenure (Years) | Ben Inker (21), John Thorndike (5) | |||
| Website | http://www.gmo.com | |||
| Fund Information | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | GMO Benchmark-Free Allocation Fund Class IV | |||
| Category | Global Allocation | |||
| Sub-Category | Allocation Miscellaneous | |||
| Prospectus Objective | Asset Allocation | |||
| Inception Date | Dec 11, 2012 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 250,000,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | 0.00 | |||
| Back End Fee | -- | |||
| Dividends and Shares | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 5.03% | |||
| Dividend | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | -- | |||
| Asset Allocation | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.19% | |||
| Stock | 62.64% | |||
| U.S. Stock | 13.62% | |||
| Non-U.S. Stock | 49.02% | |||
| Bond | 37.33% | |||
| U.S. Bond | 37.95% | |||
| Non-U.S. Bond | -0.62% | |||
| Preferred | 0.04% | |||
| Convertible | 0.00% | |||
| Other Net | -1.19% | |||
| Price History | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.77% | |||
| 30-Day Total Return | 1.54% | |||
| 60-Day Total Return | 3.29% | |||
| 90-Day Total Return | 4.74% | |||
| Year to Date Total Return | 4.74% | |||
| 1-Year Total Return | 6.68% | |||
| 2-Year Total Return | 20.89% | |||
| 3-Year Total Return | 23.53% | |||
| 5-Year Total Return | 46.61% | |||
| Price | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $26.94 | |||
| 1-Month Low NAV | $26.47 | |||
| 1-Month High NAV | $27.27 | |||
| 52-Week Low NAV | $25.46 | |||
| 52-Week Low NAV (Date) | Jan 10, 2025 | |||
| 52-Week High NAV | $27.90 | |||
| 52-Week High Price (Date) | Sep 26, 2024 | |||
| Beta / Standard Deviation | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.02 | |||
| Standard Deviation | 9.02 | |||
| Balance Sheet | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 2.34B | |||
| Operating Ratios | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.18% | |||
| Turnover Ratio | 15.00% | |||
| Performance | GBMBX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 1.68% | |||
| Last Bear Market Total Return | -3.75% | |||
